Canine Pancreatic Lipase (cPL)
Canine pancreatic lipase immunoreactivity supports diagnosis and monitoring of canine pancreatitis.
Fact Table
| Species | Canine |
|---|---|
| Biomarker | Pancreatic lipase immunoreactivity (cPL) |
| Method | Fluorescence immunoassay (FICT) |
| Unit | ng/ml |
| Category | Pancreatic |
Clinical Context
Canine pancreatic lipase immunoreactivity supports diagnosis and monitoring of canine pancreatitis.
Interpretation should always combine the quantitative result with the patient's signalment, history, clinical signs, and any other laboratory findings. A single value is rarely diagnostic on its own; serial measurements often provide more useful information.
Reference Range
Reference ranges vary by species, age and laboratory method — always interpret against the kit IFU and your in-house validation.
Related Test Kits
Related Articles
Manufacturer documentation + clinical literature cited in related articles
2026-09-12
MEDIUM — reference ranges are method-specific
FAQ
What does the Canine Pancreatic Lipase (cPL) test measure?
Migibio's Canine Pancreatic Lipase (cPL) test is a quantitative fluorescence immunoassay (FICT) run on the FIA680/FIA880 analyzer. It is intended as an aid in clinical assessment: Canine pancreatic lipase immunoreactivity supports diagnosis and monitoring of canine pancreatitis. The exact specimen, sample handling, and reporting units are specified in the kit IFU.
When is canine pancreatic lipase testing most useful?
When acute pancreatitis is suspected in a vomiting, painful, or inappetent patient, and to monitor recovery. Interpret pancreatic lipase results with the full clinical picture. For dogs, use the result with the clinical history, physical examination, and any other laboratory findings.
Why does this Data Hub not publish a universal reference range?
Reference ranges vary by species, age and laboratory method — always interpret against the kit IFU and your in-house validation.